Gene: NONO
Official Full Name: non-POU domain containing octamer bindingprovided by HGNC
Gene Summary: This gene encodes an RNA-binding protein which plays various roles in the nucleus, including transcriptional regulation and RNA splicing. A rearrangement between this gene and the transcription factor E3 gene has been observed in papillary renal cell carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes exist on Chromosomes 2 and 16. [provided by RefSeq, Feb 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00273 | NONO gRNA1-gRNA2 KO plasmid | NONO | $850 | |||
KO00678 | NONO Knockout cell line(293T) | Human | NONO | 1:3~1:6 | Negative | Online Inquiry |
NONO Gene Knockout Cell Lines are specialized research tools developed to facilitate studies in gene function and regulation. These cell lines feature targeted deletions of the NONO gene, which encodes a multifunctional nuclear protein involved in various cellular processes, including RNA metabolism, DNA damage response, and regulation of gene expression. By eliminating the NONO gene, researchers can elucidate its role in cellular pathways and assess the implications of its dysregulation in disease contexts.
The primary mechanism of action for the NONO Gene Knockout Cell Lines relies on CRISPR-Cas9 technology, enabling precise edits in the genome. This innovative approach allows for the rapid generation of knockout models that can be utilized to explore the impact of NONO depletion on cellular functions, including proliferation, differentiation, and stress responses. Scientific investigations using these cell lines can yield insights into conditions characterized by aberrant NONO activity, such as various cancers and neurodegenerative diseases.
The use of NONO Gene Knockout Cell Lines is particularly significant in both basic research and translational studies. They provide a valuable platform for pharmacological testing, genetic interaction analysis, and therapeutic target identification. Compared to alternative methods, such as RNA interference which can generate incomplete loss of function, these knockout lines offer a more definitive approach to study gene functionality by achieving complete gene disruption.
What sets our NONO Gene Knockout Cell Lines apart is their rigorously validated background, ensuring reliable results across multiple experiments. This unique combination of specificity, convenience, and reproducibility makes them indispensable for researchers and clinicians looking to advance their understanding of gene function in health and disease.
With a proven track record in providing high-quality biological products, our company is committed to delivering reliable solutions that empower scientists to push the boundaries of genetic research. Our deep expertise in gene editing technologies underpins our development of these innovative knockout cell lines, ensuring that our customers have the tools they need to unlock new discoveries in molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.